A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
Clinical trial NCT00880048 · TERMINATED
Trial details
- NCT number
- NCT00880048
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-11
- Primary completion
- 2010-06-21
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.